SCHEMBL6018368

SCHEMBL6018368

COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.68
KDR P35968 14/20 0.64
RET P07949 12/20 0.64
KIF5B P33176 10/20 0.64
ERBB2 P04626 5/20 0.61
EPHA2 P29317 4/20 0.61
EPHB4 P54760 4/20 0.61
FLT1 P17948 3/20 0.61
EPHB2 P29323 3/20 0.60
RIPK2 O43353 2/20 0.60
EPHA4 P54764 2/20 0.60
BTK Q06187 2/20 0.60
RIPK3 Q9Y572 2/20 0.60
GAK O14976 1/20 0.60
EPHB6 O15197 1/20 0.60
STK10 O94804 1/20 0.60
MAP4K4 O95819 1/20 0.60
ABL1 P00519 1/20 0.60
LCK P06239 1/20 0.60
YES1 P07947 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL907165 0.99 EGFR (0.67) EGFRKDRRETKIF5BERBB2
SCHEMBL30459542 0.96 EGFR (0.70) EGFRKDRRETKIF5BERBB2
SCHEMBL14843536 0.96 EGFR (0.70) EGFRKDRRETKIF5BERBB2
SCHEMBL29453257 0.96 EGFR (0.70) EGFRKDRRETKIF5BERBB2
Hydrochloric Acid SCHEMBL28257165 0.95 EGFR (0.69) EGFRKDRRETKIF5BERBB2
Trifluoroacetic Acid SCHEMBL907408 0.92 EGFR (0.65) EGFRKDRRETKIF5BERBB2
SCHEMBL12898759 0.89 KDR (0.63) EGFRKDRRETKIF5BERBB2
Hydrochloric Acid SCHEMBL907194 0.89 KDR (0.62) EGFRKDRRETKIF5BERBB2
SCHEMBL16938727 0.88 EGFR (0.67) EGFRKDRRETKIF5BERBB2
SCHEMBL17967495 0.87 EGFR (0.69) EGFRKDRRETKIF5BERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359332-B2 Processes for the preparation of substituted quinazolines SYMPHONY EVOLUTION, INC. (US) 2016-06-07 US disclosed
US-9163006-B2 2015-10-20 US disclosed
EP-1521747-A4 RECEPTOR-TYPE KINASE MODULATORS AND METHODS OF USE EXELIXIS INC (US) 2006-10-11 EP disclosed
EP-1521747-A2 RECEPTOR-TYPE KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2005-04-13 EP disclosed
WO-2004006846-A2 RECEPTOR-TYPE KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2004-01-22 WO disclosed